Panelists Mark Socinski, MD; Tracey Evans, MD; Alexander Drilon, MD; Vali Papadimitrakopoulou, MD; and Jared Weiss, MD, remark on the FDA approval of upfront pembrolizumab in non–small cell lung cancer and discuss data regarding the use of pembrolizumab in combination with chemotherapy.